PharmAbcine Inc. announced a private placement to issue 6,642,867 common shares at an issue price of KRW 700 per share for the gross proceeds of KRW 4,650,006,900 on June 12, 2024. The transaction will include participation from new and returning investors Tirebank Co., Ltd. 1,714,286 shares, Shim, Joo Yeob 3,285,715 shares, Yoo Hyunmi 428,572 shares, Kim Pyeongsoo 71,429 shares, Lee Dong Ho 100,000 shares, Misook Lee 71,429 shares, Cho Won Ah 28,572 shares, Seungbeom Kim 21,429 shares, Yongsung Kim 21,429 shares, Kim In Joon 14,286 shares, Jongjin Park 14,286 shares, Jongkwan Park 14,286 shares, Euijoong Kim 14,286 shares, Semi Kim 14,286 shares, Kyungchan Park 14,286 shares, Jung Seok Kim 14,286 shares, Yeom Young-il 14,286 shares, Hongwon Lee 14,286 shares, Jegeun Yoo 14,286 shares, Baek Kyung-hee 14,286 shares, Hyunmin Yoo 14,286 shares, Moon Kyungdeok 14,286 shares, Kyungryun Lee 14,286 shares, Lee Byung-kyu 28,572 shares, Excel Best Personal Investment Fund No. 4 271,429 shares, Sun Partners Co., Ltd. 285,715 shares, Netvation Partners 100,000 shares and Spera Research Co., Ltd. 14,286 shares.

The transaction has been approved by shareholders of company and restricted to a hold period and is expected to close on June 20, 2024.